USPTO serial 97392934
STEM CELL SCIENCES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAN, DAWN L
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with STEM CELL SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sona Dalal
Sona Dalal NOVEL IP191 W. 2ND STREETSANTA ANA, CA 92701UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Stem cells for medical purposes; pharmaceuticals derived from stem cells and used for anti-aging, age reversal, and for the treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment of or reversal of aging and age-related disease; nutraceuticals for use as a dietary supplement for the intended benefit of reversing the aging process and age-related disease; Nutraceuticals derived from stem cells and for use as a dietary supplement for the intended benefit of reversing the aging process and age-related disease; Nutraceuticals for use as a dietary supplement for the intended benefit of anti-aging, age reversal, treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; Nutraceuticals derived from stem cells for use as a dietary supplement for the intended benefit of anti-aging, age reversal, treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder | ACTIVE | — |
| 044 | Stem cell therapy services; medical services relating to the removal, treatment, and processing of stem cells; Medical services to slow or reverse human biological aging processes; anti-aging or longevity medical services; Medical services relating to the treatment of cardiac disease, a neurodegenerative disease, a musculoskeletal trauma, a neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; medical services, namely, the administration of compositions to humans for the purpose of slowing or reversing human biological aging processes, treating cardiac disease, treating neurodegenerative disease, treating musculoskeletal trauma, treating neurological trauma, treating type 1 diabetes, treating liver disease, treating lung disease, treating pancreatic disease, treating psychosis, and treating psychiatric disorder; medical services, namely, the administration of stem-cell based compositions to humans for the purpose of slowing or reversing human biological aging processes, treating cardiac disease, treating neurodegenerative disease, treating musculoskeletal trauma, treating neurological trauma, treating type 1 diabetes, treating liver disease, treating lung disease, treating pancreatic disease, treating psychosis, and treating psychiatric disorder; medical services, namely, stem-cell based treatments for the purpose of slowing or reversing human biological aging processes, treating cardiac disease, treating neurodegenerative disease, treating musculoskeletal trauma, treating neurological trauma, treating type 1 diabetes, treating liver disease, treating lung disease, treating pancreatic disease, treating psychosis, and treating psychiatric disorder | INACTIVE - INSUFFICIENT FEE RECEIVED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 7, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 7, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 8, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 8, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 12, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 7, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 6, 2022 | NWAP | NEW APPLICATION ENTERED | — |